Center for Anxiety and Traumatic Disorders, MGH
Boston, Massachusetts, 02114, United States
NCT Number: NCT01466127
The purpose of the study is to learn how differences in learning under mildly-stressful circumstances may be changed by taking oxytocin. Oxytocin is a hormone made naturally in the body. The investigators will also examine the impact of any anxiety, depression, and stress related symptoms on learning processes.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liquid metered-dose nasal spray, 30 IUs, administered once.
Other names: Syntocinon
Matched nasal spray placebo
Time frame: Day 2 of Conditioning (1 day post Day 1 of Conditioning)
Differences in skin conductance response (SCR) between the active vs. placebo conditions trials will be used to assess for the impact of oxytocin on fear acquisition and extinction. We will take a mean of the first two extinction trials to get this measure. Data was gathered in micro-Siemens and then underwent a square root transformation.
Massachusetts General Hospital
Other
The Effect of Oxytocin on Fear Memory Consolidation: A Novel Intervention to Prevent PTSD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT05862467
Autism, Autism Spectrum Disorder
Laramie, Wyoming, United States
View Trial DetailsNCT06130501
Chemically-Induced Disorders, Mental Disorders
Cape Girardeau, Missouri, United States
View Trial DetailsNCT05280691
Anxiety Disorders, Behavior
Winterthur, Canton of Zurich, Switzerland
View Trial Details